E

TRDA

Entrada Therapeutics, Inc.

7.27

0.16+2.25%
After Hours: 7.28  +0.01  +0.14%16:25 07/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

526.32M

469.19M

252.06M

305.83M

43.53M

Total Current Assets

440.04M

369.77M

209.88M

298.70M

39.95M

Total Non Current Assets

86.28M

99.42M

42.18M

7.13M

3.58M

Total Liabilities

97.64M

226.83M

39.50M

7.12M

3.36M

Total Current Liabilities

39.48M

158.80M

21.97M

6.72M

3.36M

Total Non Current Liabilities

58.16M

68.04M

17.53M

396.00K

0

Total Equity

428.68M

242.36M

212.55M

298.72M

40.17M

Total Stockholders Equity

428.68M

242.36M

212.55M

298.72M

40.17M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

526.32M

469.19M

252.06M

305.83M

43.53M

Total Common Shares Outstanding

37.57M

33.44M

31.39M

31.22M

29.89M

Total Preferred Shares Outstanding

--

--

--

--

--